🇺🇸 JUBBONTI in United States

FDA authorised JUBBONTI on 5 March 2024

Marketing authorisations

FDA — authorised 5 March 2024

  • Application: BLA761362
  • Marketing authorisation holder: SANDOZ INC
  • Local brand name: WYOST
  • Indication: INJECTABLE — SUBCUTANEOUS
  • Status: approved

Read official source →

FDA

  • Status: approved

JUBBONTI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is JUBBONTI approved in United States?

Yes. FDA authorised it on 5 March 2024; FDA has authorised it.

Who is the marketing authorisation holder for JUBBONTI in United States?

SANDOZ INC holds the US marketing authorisation.